← SynDRA
RODUCITABINE
SynDRA canonical compound SYN0029600 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | CDK2 | DNMT1 |
|---|
| Mechanism of action | CDK inhibitor | DNA synthesis inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
- DNA synthesis inhibitor
- DNMT1 INHIBITOR
Cross-references
Synonyms
- Fluorocyclopentenylcytosine
- RX-3117
- TV-1360
- Antimetabolite (cancer), Rexahn
- Antimetabolite (cancer), Rexahn/ Teva
- RX 3117
- fluorocyclopentenylcytosine
- Roducitabine [USAN]
- RODUCITABINE [INN]
- fluorocyclopentenyl-cytosine
- UNII-0Z4A82I0JO
- CHEBI:147412
- Roducitabine (USAN)
- RefChem:179766
- Cytidine Analog RX-3117
- RX3117
- 0Z4A82I0JO
- MFCD28502078
- Roducitabine [WHO-DD]
- orb1307765
- SCHEMBL4409591
- C10H12FN3O4
- QLLGKCJUPWYJON-HLTSFMKQSA-N
- GLXC-90462
- EX-A4776
- NSC785657
- WHO 11374
- AKOS027327327
- CS-3947
- NSC-785657
- NCGC00485875-01
- NCGC00485875-02
- AC-35336
- HY-15228
- MS-23620
- RX-3117fluorocyclopentenylcytosine, TV-1360
- T16813
- BRD-K66213167-001-01-2
- S900007480
Look up RODUCITABINE in the interactive SynDRA portal →